Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer






Dr. Ilya B. TSYRLOV graduated from Novosibirsk University Medical School (M.D. diploma with distinction). Received a Ph.D. in Biochemistry, and a D.Sci. (higher doctorate degree) in Biochemistry. Hold progressively responsible positions in academia, industry and govermental settings: Group Leader (1973-79), Head of Laboratory (1979-87), then Department of Xenobiochemistry (1987-92) at Russian National Academy of Science. In the United States: Senior Scientist at National Cancer Institute, NIH (1991-95); professor (1995-2010), then visiting associate professor (2010- ) at Mount Sinai School of Medicine, Department of Medicine. In 2005, founded and since then has served as Chief Scientific Officer at XENOTOX, Inc., an innovation science consulting non-profit company. Has forty years of experience and a world-class reputation in studies on molecular mechanisms of monooxygenases induction and drug metabolism; site-directed structure modification of analgesics, synthetic opioids, and antimalarials; research decoding mechanisms underlying human virus genome transcriptional activation by the most potent xenobiotic, dioxin. Established and developed Xenobiotical Virology, an interdisciplinary biomedical discipline dealing with mechanisms of potent xenobiotics’ effect on DRE-containing genes of human viruses, and transcription factors and cytokines linked to inflammation and malignancy pathways. Author of 4 monographs and 230+ peer reviewed publications.

Research Interest

Xenobiotical Virology